Patent protection strategy of technical standards in medical innovationWU Bin, MIAO Yan-ni, PENG Xiao-qi, LIN Guang-mei, DENG Sheng-ju494-497
Valbenazine, the first global approal for treatment of tardive dyskinesiaSUN Tao-hua, WANG Wen-cai, ZHANG Yuan-yuan498-501
Quality control and related substances of synthetic peptide drugsHU Yu-xi, JIANG Yu, HAN Tian-jiao, HE Chi-yu502-508
Introduction and analysis of FDA issued Guidance on Bioequivalence Recommendations for Specific Products related with endogenous compoundsLIU Qian, NAN Nan, LI Tao, XU Ming-di509-514
A chiral stationary phase HPLC method for determining ticagrelor isomers in ticagrelor tabletsNI Jing-wen, YE Hai-ying, ZHANG Mei, YANG Hua-xin515-520
Progress in the treatment of advanced cancer with lenvatinibZHANG Bi-yan, GU Jian-zhong, GUO Yong521-526
Research advance in effects of EGCG and AcEGCG on oxidative stress in cellsLI Xue, TAN Yang, ZHAN Ji-hua, ZHANG Yu-lin, MAN Xing-zhan, LI Ling, PEI Gang527-532
Values of microRNA in prognosis, drug resistance prediction and diagnosis of early breast cancerFAN Hong-wei, XIANG Qian, CUI Yi-min533-535
Effect of pretreatment with small dose dexmedetomidine on remifentanil-induced coughLI Ping, ZHAO Jing, WANG Dong-xin536-539